GPT and metabolic dysfunction-associated steatotic liver disease: Additionally, KT-NE-treated female mice with obesity demonstrated lower content of triglycerides, AST and ALT in serum (Fig. 9o–q), suggesting that KT-NE treatment effectively mitigated the elevation of NAFLD biomarkers associated with obesity.